A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(®)) in Patients with Metastatic Colorectal Cancer

por Ishiguro, Megumi, Watanabe, Toshiaki, Yamaguchi, Kensei, Satoh, Taroh, Ito, Hideyuki, Seriu, Taku, Sakata, Yuh, Sugihara, Kenichi
Publicado 2012

Severe Infusion Reactions to Cetuximab Occur within 1 h in Patients with Metastatic Colorectal Cancer: Results of a Nationwide, Multicenter, Prospective Registry Study of 2126 Pati...

por Yamaguchi, Kensei, Watanabe, Toshiaki, Satoh, Taroh, Ishiguro, Megumi, Izawa, Makiko, Inoshiri, Shogo, Sugihara, Kenichi, Sakata, Yuh
Publicado 2014

Histopathological atlas of desmoplastic reaction characterization in colorectal cancer

por Ueno, Hideki, Kajiwara, Yoshiki, Ajioka, Yoich, Sugai, Tamotsu, Sekine, Shigeki, Ishiguro, Megumi, Takashima, Atsuo, Kanemitsu, Yukihide
Publicado 2021

Plasma Levels of Decorin Increased in Patients during the Progression of Breast Cancer

por Hosoya, Tokuko, Oda, Goshi, Nakagawa, Tsuyoshi, Onishi, Iichiroh, Hosoya, Tadashi, Ishiguro, Megumi, Ishikawa, Toshiaki, Uetake, Hiroyuki
Publicado 2021

Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia

por Hanaoka, Marie, Ishikawa, Toshiaki, Ishiguro, Megumi, Tokura, Michiyo, Yamauchi, Shinichi, Kikuchi, Akifumi, Uetake, Hiroyuki, Yasuno, Masamichi, Kawano, Tatsuyuki
Publicado 2017

mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the fin...

por Yasuno, Masamichi, Uetake, Hiroyuki, Ishiguro, Megumi, Mizunuma, Nobuyuki, Komori, Takamichi, Miyata, Go, Shiomi, Akio, Kagimura, Tatsuo, Sugihara, Kenichi
Publicado 2019

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer

por MASUDA, TAIKI, ISHIKAWA, TOSHIAKI, MOGUSHI, KAORU, OKAZAKI, SATOSHI, ISHIGURO, MEGUMI, IIDA, SATORU, MIZUSHIMA, HIROSHI, TANAKA, HIROSHI, UETAKE, HIROYUKI, SUGIHARA, KENICHI
Publicado 2016

Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer

por Miura, Tomiyuki, Ishiguro, Megumi, Ishikawa, Toshiaki, Okazaki, Satoshi, Baba, Hironobu, Kikuchi, Akifumi, Yamauchi, Shinichi, Matsuyama, Takatoshi, Uetake, Hiroyuki, Kinugasa, Yusuke
Publicado 2020

PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia

por Orita, Fukuichiro, Ishikawa, Toshiaki, Ishiguro, Megumi, Okazaki, Satoshi, Kikuchi, Akifumi, Yamauchi, Shinichi, Matsuyama, Takatoshi, Tokunaga, Masanori, Uetake, Hiroyuki, Kinugasa, Yusuke
Publicado 2021

Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study

por Shibahara, Hidetoshi, Shiroiwa, Takeru, Ishiguro, Megumi, Nakamura, Masato, Hasegawa, Junichi, Yamaguchi, Shigeki, Masuda, Yuriko, Sakamoto, Junichi, Tomita, Naohiro, Fukuda, Takashi
Publicado 2022

Incidence and Clinical Features of Drug-induced Lung Injury in Patients with Advanced Colorectal Cancer Receiving Cetuximab: Results of a Prospective Multicenter Registry

por Satoh, Taroh, Gemma, Akihiko, Kudoh, Shoji, Sakai, Fumikazu, Yamaguchi, Kensei, Watanabe, Toshiaki, Ishiguro, Megumi, Inoshiri, Shogo, Izawa, Makiko, Sugihara, Kenichi, Sakata, Yuh
Publicado 2014

Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer

por Takahashi, Hidenori, Ishikawa, Toshiaki, Ishiguro, Megumi, Okazaki, Satoshi, Mogushi, Kaoru, Kobayashi, Hirotoshi, Iida, Satoru, Mizushima, Hiroshi, Tanaka, Hiroshi, Uetake, Hiroyuki, Sugihara, Kenichi
Publicado 2015

The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy

por Sasaki, Megumi, Ishikawa, Toshiaki, Ishiguro, Megumi, Okazaki, Satoshi, Yamauchi, Shinichi, Kikuchi, Akifumi, Matsuyama, Takatoshi, Kawada, Kenro, Tokunaga, Masanori, Uetake, Hiroyuki, Kinugasa, Yusuke
Publicado 2021

Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer

por Ishiguro, Megumi, Mochizuki, Hidetaka, Tomita, Naohiro, Shimada, Yasuhiro, Takahashi, Keiichi, Kotake, Kenjiro, Watanabe, Masahiko, Kanemitsu, Yukihide, Ueno, Hideki, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsui, Shigeyuki, Teramukai, Satoshi, Sugihara, Kenichi
Publicado 2012

Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer

por Ishiguro, Megumi, Kotake, Kenjiro, Nishimura, Genichi, Tomita, Naohiro, Ichikawa, Wataru, Takahashi, Keiichi, Watanabe, Toshiaki, Furuhata, Tomohisa, Kondo, Ken, Mori, Masaki, Kakeji, Yoshihiro, Kanazawa, Akiyoshi, Kobayashi, Michiya, Okajima, Masazumi, Hyodo, Ichinosuke, Miyakoda, Keiko, Sugihara, Kenichi
Publicado 2013

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

por Tomita, Naohiro, Kunieda, Katsuyuki, Maeda, Atsuyuki, Hamada, Chikuma, Yamanaka, Takeharu, Sato, Toshihiko, Yoshida, Kazuhiro, Boku, Narikazu, Nezu, Riichiro, Yamaguchi, Shigeki, Mishima, Hideyuki, Sadahiro, Sotaro, Muro, Kei, Ishiguro, Megumi, Sakamoto, Junichi, Saji, Shigetoyo, Maehara, Yoshihiko
Publicado 2019

Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial)

por Ueno, Hideki, Ishiguro, Megumi, Nakatani, Eiji, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsui, Shigeyuki, Teramukai, Satoshi, Murotani, Kenta, Ajioka, Yoichi, Shimazaki, Hideyuki, Maeda, Atsuyuki, Takuma, Kunio, Yoshida, Takefumi, Kambara, Takeshi, Matsuda, Keiji, Takagane, Akinori, Tomita, Naohiro, Sugihara, Kenichi
Publicado 2020

Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for s...

por Kusumoto, Tetsuya, Ishiguro, Megumi, Nakatani, Eiji, Yoshida, Motoki, Inoue, Tsukasa, Nakamoto, Yoshihiko, Shiomi, Akio, Takagane, Akinori, Sunami, Eiji, Shinozaki, Hiroharu, Takii, Yasumasa, Maeda, Atsuyuki, Ojima, Hitoshi, Hashida, Hiroki, Mukaiya, Mitsuhiro, Yokoyama, Tadashi, Nakamura, Masato, Munemoto, Yoshinori, Sugihara, Kenichi
Publicado 2018

Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial

por Ueno, Hideki, Ishiguro, Megumi, Nakatani, Eiji, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsuda, Chu, Nakamoto, Yoshihiko, Kotake, Masanori, Kurachi, Kiyotaka, Egawa, Tomohisa, Yasumasa, Keigo, Murata, Kohei, Ikawa, Osamu, Shinji, Seiichi, Murotani, Kenta, Matsui, Shigeyuki, Teramukai, Satoshi, Tomita, Naohiro, Sugihara, Kenichi
Publicado 2019

Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)

por Ueno, Hideki, Ishiguro, Megumi, Nakatani, Eiji, Ishikawa, Toshiaki, Uetake, Hiroyuki, Murotani, Kenta, Matsui, Shigeyuki, Teramukai, Satoshi, Sugai, Tamotsu, Ajioka, Yoichi, Maruo, Hirotoshi, Kotaka, Masahito, Tsujie, Masaki, Munemoto, Yoshinori, Yamaguchi, Takashi, Kuroda, Hisashi, Fukunaga, Mutsumi, Tomita, Naohiro, Sugihara, Kenichi
Publicado 2021